These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19255338)

  • 1. Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?
    Schulz R; Heusch G
    Circulation; 2009 Mar; 119(10):1355-7. PubMed ID: 19255338
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.
    Hamid T; Gu Y; Ortines RV; Bhattacharya C; Wang G; Xuan YT; Prabhu SD
    Circulation; 2009 Mar; 119(10):1386-97. PubMed ID: 19255345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1: the missing link between diabetes mellitus and heart failure.
    Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
    Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SAFE pathway for cardioprotection: is this a promising target?
    Hadebe N; Cour M; Lecour S
    Basic Res Cardiol; 2018 Jan; 113(2):9. PubMed ID: 29335904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia.
    Wang M; Tsai BM; Crisostomo PR; Meldrum DR
    Circulation; 2006 Jul; 114(1 Suppl):I282-9. PubMed ID: 16820587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of acute myocardial infarction.
    Burke AP; Virmani R
    Med Clin North Am; 2007 Jul; 91(4):553-72; ix. PubMed ID: 17640536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.
    Duerr GD; Heinemann JC; Suchan G; Kolobara E; Wenzel D; Geisen C; Matthey M; Passe-Tietjen K; Mahmud W; Ghanem A; Tiemann K; Alferink J; Burgdorf S; Buchalla R; Zimmer A; Lutz B; Welz A; Fleischmann BK; Dewald O
    Basic Res Cardiol; 2014 Jul; 109(4):425. PubMed ID: 24980781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
    Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFalpha in myocardial ischemia/reperfusion: damage vs. protection.
    Schulz R
    J Mol Cell Cardiol; 2008 Dec; 45(6):712-4. PubMed ID: 18851974
    [No Abstract]   [Full Text] [Related]  

  • 10. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization.
    Hu Y; Zhang H; Lu Y; Bai H; Xu Y; Zhu X; Zhou R; Ben J; Xu Y; Chen Q
    Basic Res Cardiol; 2011 Nov; 106(6):1311-28. PubMed ID: 21769674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning.
    Flaherty MP; Guo Y; Tiwari S; Rezazadeh A; Hunt G; Sanganalmath SK; Tang XL; Bolli R; Dawn B
    J Mol Cell Cardiol; 2008 Dec; 45(6):735-41. PubMed ID: 18824172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.
    Fu F; Zhao K; Li J; Xu J; Zhang Y; Liu C; Yang W; Gao C; Li J; Zhang H; Li Y; Cui Q; Wang H; Tao L; Wang J; Quon MJ; Gao F
    Sci Rep; 2015 Dec; 5():17927. PubMed ID: 26659007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
    Nishio R; Matsumori A
    Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
    [No Abstract]   [Full Text] [Related]  

  • 15. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
    Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure.
    Isidoro Tavares N; Philip-Couderc P; Baertschi AJ; Lerch R; Montessuit C
    Cardiovasc Res; 2009 Sep; 83(4):726-36. PubMed ID: 19460779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction.
    Zhu X; Bagchi A; Zhao H; Kirschning CJ; Hajjar RJ; Chao W; Hellman J; Schmidt U
    Crit Care Med; 2007 Mar; 35(3):886-92. PubMed ID: 17255871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of myocardial stromal cell-derived factor 1α/CXCL12 by tumor necrosis factor signaling.
    Wang M; Wang L; Huang C; Wang IW; Turrentine MW
    J Surg Res; 2017 Jan; 207():155-163. PubMed ID: 27979472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.
    Lacerda L; Somers S; Opie LH; Lecour S
    Cardiovasc Res; 2009 Nov; 84(2):201-8. PubMed ID: 19666677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.